LEADER 01187nam  2200337Ia 450 
001 9910697101303321
005 20230902161937.0
035   $a(CKB)5470000002383884
035   $a(OCoLC)569384486
035   $a(EXLCZ)995470000002383884
100   $a20100325d2002      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $enasal spray and inhalation solution, suspension, and spray drug products : chemistry, manufacturing, and controls documentation
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research,$d[2002]
215   $a1 electronic resource (45 pages)
300   $a"CMC."
300   $a"July 2002."
517   $aGuidance for industry 
606   $aRespiratory therapy$zUnited States
615  0$aRespiratory therapy
712 02$aCenter for Drug Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910697101303321
996   $aGuidance for industry$93434577
997   $aUNINA